Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease

Translational Psychiatry, Published online: 27 October 2023; doi:10.1038/s41398-023-02630-zChronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer’s disease
Source: Translational Psychiatry - Category: Psychiatry Authors: Source Type: research
More News: Brain | Neurology | Psychiatry